This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Bio View's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was ₪0.186. Bio View's 10-Year median PS Ratio is 1.6667. Therefore, the Median PS Value for today is ₪0.31.
As of today (2025-04-27), Bio View's share price is ₪0.309. Bio View's Median PS Value is ₪0.31. Therefore, Bio View's Price to Median PS Value for today is 1.00.
The historical rank and industry rank for Bio View's Median PS Value or its related term are showing as below:
XTAE:BIOV'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.8 Med: 0.96 Max: 1.43
Current: 1
During the past 13 years, the highest Price to Median PS Value of Bio View was 1.43. The lowest was 0.80. And the median was 0.96.
XTAE:BIOV's Price-to-Median-PS-Value is ranked worse than 69.07% of 291
companies
in the Medical Devices & Instruments industry
Industry Median: 0.76
vs XTAE:BIOV: 1.00
Bio View Median PS Value Historical Data
The historical data trend for Bio View's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Bio View's Median PS Value
For the Medical Devices subindustry, Bio View's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bio View's Price-to-Median-PS-Value Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bio View's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Bio View's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 1.6667.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Bio View's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was ₪0.186.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bio View (XTAE:BIOV) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Bio View's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
0.309
/
0.31
=
1.00
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bio View Median PS Value Related Terms
Thank you for viewing the detailed overview of Bio View's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Bio View Ltd is an Israel based company engaged in the research, development, manufacture, marketing, and sale of computerized systems for identification of rate cells and test for detection of cancer. It manufactures and markets automated cell imaging and analysis solutions for use in cytology, cytogenetic, pathology clinical and research laboratories. Geographically, the group has its business presence in Israel, USA, and other countries, of which majority of the revenue is derived from the USA.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XTAE:BIOV has been successfully added to your 